Price $20.23 |
Market Cap
208M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
31.6
|
P/B
1.38
|
P/S
4.73
|
Dividend %
-
|
|
P/CF
14.7
|
P/FCF
12.7
|
Op. Cash Flow
22.6K
|
FCF
1.3
|
|
Op. Margin
52.60%
|
Net Margin
29.90%
|
ROE
9.60%
|
ROI
12.10%
|
|
ROA
8.30%
|
EPS Growth
103.50%
|
Current Ratio
7.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| LogicMark Inc (LGMK) | $1.18 | - | - | 12.5M | Strong Buy |
| Bimi International Medical Inc (BIMI) | $0.67 | - | - | 4.3M | Strong Buy |
| Lineage Cell Therapeutics Inc (LCTX) | $1.43 | - | - | 212.2M | Strong Buy |
| Endo International PLC (ENDP) | $0.71 | - | - | 124.1M | Strong Buy |
| Chembio Diagnostics Inc (CEMI) | $0.65 | - | - | 22.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
